Description

1,28,68,000 equity shares of Ind-Swift Laboratories Ltd listed on BSE with effect from October 7, 2025, issued on preferential basis pursuant to conversion of warrants.

Summary

BSE has announced the listing and permission to trade 1,28,68,000 new equity shares of Ind-Swift Laboratories Ltd (Scrip Code: 532305) with effect from Tuesday, October 7, 2025. These shares were issued at a premium of Rs. 111/- (total issue price Rs. 121/-) to Promoters and Non-Promoters on a preferential basis pursuant to conversion of warrants. The shares rank pari-passu with existing equity shares.

Key Points

  • Total new securities listed: 1,28,68,000 equity shares of Rs. 10/- each
  • Issue price: Rs. 121/- per share (face value Rs. 10/- + premium Rs. 111/-)
  • Allotment done in three tranches: 65,82,876 shares on 02/07/2025, 51,85,124 shares on 21/07/2025, and 11,00,000 shares on 01/08/2025
  • Trading commences from October 7, 2025
  • ISIN: INE915B01019
  • Distinctive Numbers: 60618861 to 73486860
  • Shares rank pari-passu with existing equity shares
  • Various lock-in periods apply to different tranches of shares

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification following preferential allotment procedures.

Compliance Requirements

  • Trading members must note the new securities are available for trading from October 7, 2025
  • Lock-in restrictions must be observed as specified:
    • 11,00,000 shares (Dist. Nos. 60618861-61718860) locked until 10/04/2027
    • 54,82,876 shares (Dist. Nos. 61718861-67201736) locked until 10/04/2026
    • 7,00,000 shares (Dist. Nos. 67201737-67901736) locked until 10/04/2027
    • 44,85,124 shares (Dist. Nos. 67901737-72386860) locked until 10/04/2026
    • 11,00,000 shares (Dist. Nos. 72386861-73486860) locked until 10/04/2027

Important Dates

  • Allotment Dates: July 2, 2025 (65,82,876 shares), July 21, 2025 (51,85,124 shares), August 1, 2025 (11,00,000 shares)
  • Trading Commencement: October 7, 2025
  • Lock-in Expiry Dates: April 10, 2026 (for 99,67,900 shares) and April 10, 2027 (for 29,00,000 shares)
  • Notice Date: October 6, 2025

Impact Assessment

Market Impact: The listing of 1.29 crore new equity shares represents a significant capital infusion through warrant conversion. This will increase the total outstanding shares and result in dilution for existing shareholders. The staggered allotment across three dates and varying lock-in periods indicate structured fund raising with both promoter and non-promoter participation.

Liquidity Impact: Medium - The addition of 1.29 crore shares increases the float, though a substantial portion (29 lakh shares) is locked until April 2027 and 99.68 lakh shares until April 2026.

Investor Impact: Existing shareholders face dilution from the preferential allotment. The issue price of Rs. 121/- will serve as a reference point for market valuation. The lock-in periods provide stability assurance as promoters and investors cannot immediately exit.

Impact Justification

Medium importance as it involves listing of 1.29 crore new equity shares through warrant conversion, representing a significant capital raise with lock-in periods. Medium impact as it affects existing shareholders through dilution but follows standard preferential allotment process.